Sign in
4

Changes in Ownership

Enveric Biosciences, Inc. Filed Acc 0000921895-18-002456

Options or other derivatives

  • Director acquired 45,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Shad James Director 2018-08-20 Grant or award · Option (Right to Buy) +35,000 35,000 D
Shad James Director 2018-08-20 Grant or award · Restricted Stock Unit +10,000 10,000 D
Loading xslF345X03/form410211008sha_8202018.xml…